Following Inocras & Summit Pharmaceuticals International Corporation?
Get the free weekly contract digest
The latest new contracts, like Inocras & Summit Pharmaceuticals International Corporation’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Inocras and Summit Pharmaceuticals International Corporation Collaborate to Revolutionize Healthcare in Japan
Nov 06, 2024•over 1 year ago
Contract Type
partnership
San DiegoBiotechnologyHealth CareGeneticsDescription
Inocras Inc. and Summit Pharmaceuticals International Corporation have signed a Memorandum of Understanding to jointly explore the commercialization of whole genome sequencing (WGS) analysis services in Japan. The collaboration aims to leverage genomic data and bioinformatics to revolutionize healthcare in Japan by better understanding and treating genetic conditions, especially cancer.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months